Stock ORGANOVO HOLDINGS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Organovo Holdings Inc Nyse

Equities

US68620A1043

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Organovo Holdings Inc
04-15 Organovo's fatty liver disease drug meets main goal in mid-stage study RE
04-15 Organovo Holdings, Inc. Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. ONVO Stock
  4. Stock
  5. News Organovo Holdings Inc
  6. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW